10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 31, 2016

or

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                                  to

Commission file number: 333-183839

WISHBONE PET PRODUCTS INC.

(Exact name of registrant as specified in its charter)

Nevada	Pending
State or other jurisdiction of incorporation or organization	(I.R.S. Employer Identification No.)

2857 Sherwood Heights Drive, Oakville, Ontario, L6J 7J9

(Address of principal executive offices) (Zip Code)

(888) 414-6832

Registrant’s telephone number, including area code

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [  ] No [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[  ]	Accelerated filer	[  ]
Non-accelerated filer	[  ]	Smaller reporting company	[X]
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [  ]

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

3,750,000 shares of common stock are issued and outstanding as of September 21, 2016.

INDEX
		Page
PART I	FINANCIAL INFORMATION	3
Item 1.	Financial Statements (unaudited)	3
	BALANCE SHEETS as of July 31, 2016 and April 30, 2016	3
	STATEMENTS OF OPERATIONS for the Three Months ended July 31, 2016 and 2015, and for the period since inception to July 31, 2016	4
	STATEMENTS OF SHAREHOLDERS’ EQUITY for the period since inception	5
	STATEMENTS OF CASH FLOWS for the Three Months Ended July 31, 2016 and July 31, 2015, and for the period since inception to July 31, 2016	6
	NOTES TO THE UNAUDITED INTERIM FINANCIAL STATEMENTS	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	9
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	11
Item 4.	Controls and Procedures	11
PART II	OTHER INFORMATION	12
Item 1.	Legal Proceedings	12
Item 1A.	Risk Factors	12
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	12
Item 3.	Defaults Upon Senior Securities.	12
Item 4.	(Removed and reserved)	12
Item 5.	Other Information.	12
Item 6.	Exhibits	13
SIGNATURES		14

 2

PART I FINANCIAL INFORMATION 

Item 1. Financial Statements (unaudited)

WISHBONE PET PRODUCTS INC.

BALANCE SHEETS

(Unaudited)

	July 31, 2016			April 30, 2016
				(Audited)
ASSETS
Cash	$	3,322		$	635
TOTAL ASSETS	$	3,322		$	635
LIABILITIES & SHAREHOLDER’S EQUITY
LIABILITIES
Accounts payable & Accrued liabilities	$	45,112		$	39,020
Loans payable		82,925			80,225
		128,037			119,245
SHAREHOLDER’S EQUITY
Capital stock authorized: 200,000,000 common shares with a par value $0.001
Issued and outstanding: 3,750,000 common shares
Capital stock	$	3,750		$	3,750
Shares subscribed		-			-
Additional paid-in capital		18,250			18,250
Deficit accumulated during the developmental stage		(146,715	)		(140,610	)
		(124,715	)		(118,610	)
TOTAL LIABILITIES & SHAREHOLDER’S EQUITY	$	3,322		$	635

 3

  WISHBONE PET PRODUCTS INC.

  INCOME STATEMENTS

  For the three months ended July 31, 2016 and 2015

(Unaudited)

	For the three months
	ended July 31, 2016
	2016			2015
OPERATING EXPENSES
Professional fees	$	2,975		$	4,875
General & administrative expenses		724			6,116
TOTAL EXPENSES		3,699			10,991
OPERATING LOSS	$	(3,699	)	$	(10,991	)
OTHER EXPENSES
Interest on loans		2,406			1,557
OTHER INCOME
Interest income		-			-
NET INCOME/(LOSS)	$	(6,105	)	$	(12,548	)
Net loss per share, basic and diluted	$	(0.002	)	$	(0.003	)
Weighted average common shares outstanding basic and diluted		3,750,000			3,644,022

 4

WISHBONE PET PRODUCTS INC.

STATEMENT OF CHANGES IN STOCKHOLDER’S EQUITY

(Unaudited)

	Common Stock
	200,000,000 shares authorized							Additional					Total
	Shares		Par Value		Shares			Paid in		Accumulated			Shareholder’s
	Issued		$.001 per share		Subscribed			Capital		Deficit			Equity
Balance, April 30, 2014		3,500,000	$	3,500	$	-		$	13,500	$	(67,522	)	$	(50,522	)
Shares subscribed at $0.02						5,000								5,000
Net income/loss											(24,534	)		(24,534	)
Balance, April 30, 2015		3,500,000	$	3,500	$	5,000		$	13,500	$	(92,056	)	$	(70,056	)
Shares issued at $0.02		250,000		250		(5,000	)		4,750					-
Net income/loss											(48,554	)		(48,554	)
Balance, April 30, 2016		3,750,000	$	3,750	$	-		$	18,250	$	(140,610	)	$	(118,610	)
Net income/loss											(6,105	)		(6,105	)
Balance, July 31, 2016		3,750,000	$	3,750	$	-		$	18,250	$	(146,715	)	$	(124,715	)

 5

WISHBONE PET PRODUCTS INC.

STATEMENT OF CASH FLOWS

(Unaudited)

	For the three months
	ended July 31,
	2016			2015
Net income/(loss)	$	(6,105	)	$	(12,548	)
Adjustments to reconcile net income to net cash:
Changes in current assets and liabilities:
Accounts payable		6,092			2,218
Net cash used in operating activities	$	(13	)	$	(10,330	)
Cash Flows from Investing Activities	$	-		$	-
Net cash used in investing activities	$	-		$	-
Cash Flows from Financing Activities
Proceeds from the issuance of common stock	$	-		$	5,000
Shares subscribed		-			(5,000	)
Proceeds from loans payable		2,700			10,000
Net cash provided by financing activities	$	2,700		$	10,000
Net cash flows from operations	$	2,687		$	(330	)
Cash and cash equivalents, beginning of period	$	635		$	1,011
Cash and cash equivalents, end of period	$	3,322		$	681

 6

WISHBONE PET PRODUCTS INC.

Notes to the Financial Statement

July 31, 2016

(Unaudited)

Note 1 Nature and Continuance of Operations

Wishbone Pet Products Inc. was incorporated in the State of Nevada on July 30, 2009. The Company has been in the development stage since its formation and has not realized any revenues from its planned operations. The Company is primarily engaged in the business of developing, manufacturing, marketing and selling dog waste removal devices.

The Company has chosen an April 30 fiscal year end.

Note 2 Basis of Presentation – Going Concern Uncertainties

These financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern. The Company is at its early stages of development and has limited operations, and has sustained operating losses resulting in a deficit.

The Company has accumulated a deficit of $146,715 since inception, has yet to achieve profitable operations and further losses are anticipated in the development of its business. The Company’s ability to continue as a going concern is in substantial doubt and is dependent upon obtaining financing and/or achieving a sustainable profitable level of operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company may seek additional equity as necessary and it expects to raise funds through private or public equity investment or loans from directors of the Company in order to support existing operations. There is no assurance that such additional funds will be available for the Company on acceptable terms, if at all.

Note 3 Interim Reporting and Significant Accounting Policies

The interim condensed financial statements are prepared under the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America. While the information presented is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, result of operation and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. All adjustments are of a normal recurring nature. It is suggested that the interim condensed financial statements be read in conjunction with the Company’s April 30, 2016 annual financial statements. Operating results for the three month period ended July 31, 2016 are not necessarily indicative of the results that can be expected for the year ended April 30, 2017.

 7

There have been no changes in the accounting policies from those disclosed in the notes to the audited financial statements for the year ended April 30, 2016.

Recently issued accounting pronouncements

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. Management does not believe that any pronouncement not yet effective but recently issued by the FASB (including its Emerging Issues Task Force), the AICPA or the SEC would, if adopted, have a material effect on the accompanying financial statements.

Note 4 Notes payable

The Company entered into 7 note payables. They are all due within 30 days following written demand and bears a monthly interest rate of 1% (12% per annum).

	Principal		Interest
	Amount		Accrued		Total
Dec 31 12		17,000		7,310		24,310
Aug 13 13		20,000		7,100		27,100
Dec 04 14		11,000		2,188		13,188
Jun 26 15		10,000		1,317		11,317
Jan 25 16		4,500		271		4,771
Mar 22 16		17,725		798		18,523
Jul 28 16		2,700				2,700
	$	82,925	$	18,983	$	101,908

Note 5 Common Shares

During the year ended April 30, 2016, the Company issued 250,000 common shares to investors valued at $0.02 per share.

Note 6 Subsequent events

The Company evaluated all events or transaction that occurred after July 31, 2016 up through date the Company issued these financial statements and found no subsequent events that needed to be reported.

 8

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical or current facts are “forward-looking statements” made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the “Act”) and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

GENERAL

Wishbone Pet Products Inc. was incorporated under the laws of the State of Nevada, U.S. on July 30, 2009. Our registration statement on Form S-1 was filed with the Securities and Exchange Commission was declared effective on February 14, 2013. We have filed post-effective amendments to this registration statement, but as of the date of this quarterly report, the Securities & Exchange Commission has not declared any such amendments effective.

We intend to commence business operations by developing, manufacturing, marketing, and selling dog waste removal devices. We are currently considered a development stage company. To date, our president, Rami Tabet, has developed a device concept that permits the user to enclose dog waste in a plastic bag this is contained inside of a sealed plastic case. The user can then disposed of the plastic bag without direct contact. To date, we have not manufactured or sold any dog waste removal devices. We are considered to be a “shell company”, which is a company with either no or nominal operations or assets, or assets consisting solely of cash and cash equivalents. An investment in the shares of a shell company should be considered highly illiquid given the resale restrictions that apply to them. In order to continue our business plan, we need to transform our device concept into a working prototype that is suitable for mass production and then enter into an agreement with a suitable third party for manufacture. We then intend to initially distribute our products in North America with a view to expanding our market focus depending on our initial success.

RESULTS OF OPERATIONS

Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

Three-Month Period Ended July 31, 2016 Compared to the Three-Month Period Ended July 31, 2015.

Our net loss for the three-month period ended July 31, 2016 was $6,105 (2015: $12,548), which consisted of professional fees of $2,975 (2015: $4,875), general and administration expenses of $724 (2015: $6,116), and interest on loans of $2,406 (2015: $1,557). We did not generate any revenue during either three-month period in fiscal 2016 or 2015. The higher expenses in the previous fiscal year primarily relate to an increase in accounting, audit, and transfer agent fees.

 9

The weighted average number of shares outstanding was 3,750,000 for the three-month periods ended July 31, 2016 (2015: 3,644,022). As of the date of this quarterly report, our issued and outstanding capital consists of 3,750,000 shares of common stock.

LIQUIDITY AND CAPITAL RESOURCES

As at July 31, 2016, our current assets were $3,322 compared to $635 at April 30, 2016. As at July 31, 2016, our current liabilities were $128,037 compared to $119,245 at April 30, 2016. Current liabilities at July 31, 2016 were comprised of $82,925 in loans payable and $45,112 in accounts payable and accrued liabilities.

Stockholders’ deficit increased from $146,715 as of April 30, 2016 to $118,610 as of July 31, 2016.

Cash Flows from Operating Activities

We have not generated positive cash flows from operating activities. For the three-month period ended July 31, 2016, net cash flows used in operating activities were $13 consisting of a net loss of $6,105, which was offset by a $6,092 non-cash component of accounts payable. For the three-month period ended July 31, 2015, net cash flows used in operating activities were $10,330.

Cash Flows from Financing Activities

We have financed our operations primarily from either the issuance of our shares of common stock or from loans. During the three-month period ended July 31, 2016, we received a shareholder loan of $2,700. In the comparable period in 2015, we received $10,000 in proceeds as a shareholder loan.

PLAN OF OPERATION AND FUNDING

We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business.

Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances of securities and director loans. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. We will have to raise additional funds in the next twelve months in order to sustain and expand our operations. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of our common stock. We have and will continue to seek to obtain short-term loans from our directors, although no future arrangement for additional loans has been made. We do not have any agreements with our directors concerning these loans. We do not have any arrangements in place for any future equity financing.

 10

OFF-BALANCE SHEET ARRANGEMENTS

As of the date of this report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

GOING CONCERN

The independent auditors’ report accompanying our April 30, 2016 financial statements contained an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared “assuming that we will continue as a going concern,” which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

No report required.

ITEM 4. CONTROLS AND PROCEDURES

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of July 31, 2016. Based on that evaluation, our management concluded that our disclosure controls and procedures were effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Such officer also confirmed that there was no change in our internal control over financial reporting during the three-month period ended July 31, 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 11

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

No report required.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

No report required.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No report required.

ITEM 5. OTHER INFORMATION

No report required.

 12

ITEM 6. EXHIBITS

Exhibits:

31.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act
32.1	Certification of Chief Executive Officer and Chief Financial Officer Under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act.
101	Interactive data files pursuant to Rule 405 of Regulation S-T.

 13

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WISHBONE PET PRODUCTS INC.
Dated: September 22, 2016	By:	/s/ Rami Tabet
		Rami Tabet, President and Chief Executive Officer and Chief Financial Officer

 14

EX-31.1

EXHIBIT 31.1

Wishbone Pet Products Inc.
CERTIFICATIONS PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Rami Tabet, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Wishbone Pet Products Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15(d)-15(f)) for the registrant and I have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. I have disclosed, based on my most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	September 22, 2016
By:	/s/ Rami Tabet
	Rami Tabet
	Chief Executive Officer and Chief Financial Officer
	(Principal Executive Officer, Principal Financial
	Officer and Principal Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Rami Tabet, Chief Executive Officer and Chief Financial Officer of Wishbone Pet Products Inc. (the “Company”) hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a) the Quarterly Report on Form 10-Q of the Company for the period ended July 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(b) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	September 22, 2016
By:	/s/ Rami Tabet
	Rami Tabet
	Chief Executive Officer and Chief Financial Officer
	(Principal Executive Officer, Principal Financial
	Officer and Principal Accounting Officer)

`

XML

Document and Entity Information - shares	3 Months Ended
	Jul. 31, 2016	Sep. 21, 2016
Document And Entity Information
Entity Registrant Name	Wishbone Pet Products Inc.
Entity Central Index Key	0001557668
Document Type	10-Q
Document Period End Date	Jul. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--04-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		3,750,000
Trading Symbol	WSBP
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2017

XML

Balance Sheets (Unaudited) - USD ($)	Jul. 31, 2016	Apr. 30, 2016
ASSETS
Cash	$ 3,322	$ 635
TOTAL ASSETS	3,322	635
LIABILITIES
Accounts payable & Accrued liabilities	45,112	39,020
Loans payable	82,925	80,225
TOTAL LIABILITIES	128,037	119,245
SHAREHOLDER'S EQUITY
Capital stock authorized: 200,000,000 common shares with a par value $0.001 Issued and outstanding: 3,750,000 common shares Capital stock	3,750	3,750
Shares subscribed
Additional paid-in capital	18,250	18,250
Deficit accumulated during the developmental stage	(146,715)	(140,610)
TOTAL SHAREHOLDER'S EQUITY	(124,715)	(118,610)
TOTAL LIABILITIES & SHAREHOLDER'S EQUITY	$ 3,322	$ 635

XML

Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jul. 31, 2016	Apr. 30, 2016
Statement of Financial Position [Abstract]
Common stock, shares authorized	200,000,000	200,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	3,750,000	3,750,000
Common stock, shares outstanding	3,750,000	3,750,000

XML

Income Statements (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2016	Jul. 31, 2015
OPERATING EXPENSES
Professional fees	$ 2,975	$ 4,875
General & administrative expenses	724	6,116
TOTAL EXPENSES	3,699	10,991
OPERATING LOSS	(3,699)	(10,991)
OTHER EXPENSES
Interest on loans	2,406	1,557
OTHER INCOME
Interest income
NET INCOME/(LOSS)	$ (6,105)	$ (12,548)
Net loss per share, basic and diluted	$ (0.002)	$ (0.003)
Weighted average common shares outstanding basic and diluted	3,750,000	3,644,022

XML

Statement of Changes in Stockholder's Equity (Unaudited) - USD ($)	Common Stock [Member]	Shares Subscribed [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Apr. 30, 2014	$ 3,500		$ 13,500	$ (67,522)	$ (50,522)
Balance, shares at Apr. 30, 2014	3,500,000
Shares subscribed at $0.02		5,000			5,000
Net income/loss				(24,534)	(24,534)
Balance at Apr. 30, 2015	$ 3,500	5,000	13,500	(92,056)	(70,056)
Balance, shares at Apr. 30, 2015	3,500,000
Shares issued at $0.02	$ 250	(5,000)	4,750
Shares issued at $0.02, shares	250,000
Net income/loss				(48,554)	(48,554)
Balance at Apr. 30, 2016	$ 3,750		18,250	(140,610)	(118,610)
Balance, shares at Apr. 30, 2016	3,750,000
Net income/loss				(6,105)	(6,105)
Balance at Jul. 31, 2016	$ 3,750		$ 18,250	$ (146,715)	$ (124,715)
Balance, shares at Jul. 31, 2016	3,750,000

XML

Statement of Changes in Stockholder's Equity (Unaudited) (Parenthetical)	Jul. 31, 2016 $ / shares shares
Statement of Stockholders' Equity [Abstract]
Common stock, shares authorized | shares	200,000,000
Common stock shares subscribed price per share	$ 0.02
Common stock shares issued price per share	0.02
Common stock, par value	$ 0.001

XML

Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jul. 31, 2016	Jul. 31, 2015
Statement of Cash Flows [Abstract]
Net income/(loss)	$ (6,105)	$ (12,548)
Changes in current assets and liabilities:
Accounts payable	6,092	2,218
Net cash used in operating activities	(13)	(10,330)
Cash Flows from Investing Activities
Net cash used in investing activities
Cash Flows from Financing Activities
Proceeds from the issuance of common stock		5,000
Shares subscribed		(5,000)
Proceeds from loans payable	2,700	10,000
Net cash provided by financing activities	2,700	10,000
Net cash flows from operations	2,687	(330)
Cash and cash equivalents, beginning of period	635	1,011
Cash and cash equivalents, end of period	$ 3,322	$ 681

XML

Nature and Continuance of Operations

3 Months Ended

Jul. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature and Continuance of Operations

Note 1 Nature and Continuance of Operations

Wishbone Pet Products Inc. was incorporated in the State of Nevada on July 30, 2009. The Company has been in the development stage since its formation and has not realized any revenues from its planned operations. The Company is primarily engaged in the business of developing, manufacturing, marketing and selling dog waste removal devices.

The Company has chosen an April 30 fiscal year end.

XML

Basis of Presentation - Going Concern Uncertainties

3 Months Ended

Jul. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation - Going Concern Uncertainties

Note 2 Basis of Presentation – Going Concern Uncertainties

These financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern. The Company is at its early stages of development and has limited operations, and has sustained operating losses resulting in a deficit.

The Company has accumulated a deficit of $146,715 since inception, has yet to achieve profitable operations and further losses are anticipated in the development of its business. The Company’s ability to continue as a going concern is in substantial doubt and is dependent upon obtaining financing and/or achieving a sustainable profitable level of operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company may seek additional equity as necessary and it expects to raise funds through private or public equity investment or loans from directors of the Company in order to support existing operations. There is no assurance that such additional funds will be available for the Company on acceptable terms, if at all.

XML

Interim Reporting and Significant Accounting Policies

3 Months Ended

Jul. 31, 2016

Accounting Policies [Abstract]

Interim Reporting and Significant Accounting Policies

Note 3 Interim Reporting and Significant Accounting Policies

The interim condensed financial statements are prepared under the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America. While the information presented is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, result of operation and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. All adjustments are of a normal recurring nature. It is suggested that the interim condensed financial statements be read in conjunction with the Company’s April 30, 2016 annual financial statements. Operating results for the three month period ended July 31, 2016 are not necessarily indicative of the results that can be expected for the year ended April 30, 2017.

There have been no changes in the accounting policies from those disclosed in the notes to the audited financial statements for the year ended April 30, 2016.

Recently issued accounting pronouncements

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. Management does not believe that any pronouncement not yet effective but recently issued by the FASB (including its Emerging Issues Task Force), the AICPA or the SEC would, if adopted, have a material effect on the accompanying financial statements.

XML

Notes Payable

3 Months Ended

Jul. 31, 2016

Debt Disclosure [Abstract]

Notes Payable

Note 4 Notes payable

The Company entered into 7 note payables. They are all due within 30 days following written demand and bears a monthly interest rate of 1% (12% per annum).

	Principal		Interest
	Amount		Accrued		Total
Dec 31 12		17,000		7,310		24,310
Aug 13 13		20,000		7,100		27,100
Dec 04 14		11,000		2,188		13,188
Jun 26 15		10,000		1,317		11,317
Jan 25 16		4,500		271		4,771
Mar 22 16		17,725		798		18,523
Jul 28 16		2,700				2,700
	$	82,925	$	18,983	$	101,908

XML

Common Shares

3 Months Ended

Jul. 31, 2016

Equity [Abstract]

Common Shares

Note 5 Common Shares

During the year ended April 30, 2016, the Company issued 250,000 common shares to investors valued at $0.02 per share.

XML

Subsequent Events

3 Months Ended

Jul. 31, 2016

Subsequent Events [Abstract]

Subsequent Events

Note 6 Subsequent events

The Company evaluated all events or transaction that occurred after July 31, 2016 up through date the Company issued these financial statements and found no subsequent events that needed to be reported.

XML

Interim Reporting and Significant Accounting Policies (Policies)

3 Months Ended

Jul. 31, 2016

Accounting Policies [Abstract]

Recently Issued Accounting Pronouncements

Recently issued accounting pronouncements

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. Management does not believe that any pronouncement not yet effective but recently issued by the FASB (including its Emerging Issues Task Force), the AICPA or the SEC would, if adopted, have a material effect on the accompanying financial statements.

XML

Notes Payable (Tables)

3 Months Ended

Jul. 31, 2016

Debt Disclosure [Abstract]

Schedule of Notes Payable

The Company entered into 7 note payables. They are all due within 30 days following written demand and bears a monthly interest rate of 1% (12% per annum).

	Principal		Interest
	Amount		Accrued		Total
Dec 31 12		17,000		7,310		24,310
Aug 13 13		20,000		7,100		27,100
Dec 04 14		11,000		2,188		13,188
Jun 26 15		10,000		1,317		11,317
Jan 25 16		4,500		271		4,771
Mar 22 16		17,725		798		18,523
Jul 28 16		2,700				2,700
	$	82,925	$	18,983	$	101,908

XML

Basis of Presentation - Going Concern Uncertainties (Details Narrative) - USD ($)	Jul. 31, 2016	Apr. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit since inception	$ 146,715	$ 140,610

XML

Notes Payable (Details Narrative)	3 Months Ended
	Jul. 31, 2016
Debt Disclosure [Abstract]
Note due period	30 days
Notes payable interest rate per month	1.00%
Notes payable interest rate per annum	12.00%

XML

Notes Payable - Schedule of Notes Payable (Details) - USD ($)	Jul. 31, 2016	Jul. 28, 2016	Mar. 22, 2016	Jan. 25, 2016	Jun. 26, 2015	Dec. 04, 2014	Aug. 13, 2013	Dec. 31, 2012
Principal Amount	$ 82,925
Interest Accrued	18,983
Notes payable total	$ 101,908
Note One [Member]
Principal Amount								$ 17,000
Interest Accrued								7,310
Notes payable total								$ 24,310
Note Two [Member]
Principal Amount							$ 20,000
Interest Accrued							7,100
Notes payable total							$ 27,100
Note Three [Member]
Principal Amount						$ 11,000
Interest Accrued						2,188
Notes payable total						$ 13,188
Note Four [Member]
Principal Amount					$ 10,000
Interest Accrued					1,317
Notes payable total					$ 11,317
Note Five [Member]
Principal Amount				$ 4,500
Interest Accrued				271
Notes payable total				$ 4,771
Note Six [Member]
Principal Amount			$ 17,725
Interest Accrued			798
Notes payable total			$ 18,523
Note Seven [Member]
Principal Amount		$ 2,700
Interest Accrued
Notes payable total		$ 2,700

XML

Common Shares (Details Narrative) - $ / shares	12 Months Ended
	Apr. 30, 2016	Jul. 31, 2016
Common stock price per share		$ 0.02
Investors [Member]
Number of common stock shares issued during the period	250,000
Common stock price per share	$ 0.02